On August 28,2025, NASS announced the cancellation of the Farm Labor Survey. The discontinuance was officially posted to the Federal Register on September 3. Countless stakeholders including farmers, ...
An objective response rate of 48.2% was observed with ifinatamab deruxtecan in these previously treated patients Discussions with global regulatory authorities underway SCLC is aggressive and ...
Zongertinib shows a 71% response rate and 12.4 months median progression-free survival in HER2-mutated NSCLC, with minimal adverse events. Patient-reported outcomes indicate rapid improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback